#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Becker's muscular dystrophy Haemophilia A with anti factor VIII Chronic graft versus host disease Diffuse large B-cell lymphoma Juvenile idiopathic arthritis Carcinoid tumour Plasma cell myeloma Heritable pulmonary arterial hypertension Chronic granulomatous disease Haematological malignancy Bulbospinal muscular atrophy congenital Uveitis Burkitt's lymphoma refractory Polyneuropathy Lymphatic malformation More trials…

    Learn about Rare Diseases

    Inclusion body myositis Behcet’s syndrome – Basic Information Angelman’s syndrome Hereditary ataxia – Life with Disease Langerhans’ cell histiocytosis – Trials in Disease Pulmonary fibrosis – Diagnostics Urea cycle disorder – Basic Information Cerebral arteriovenous malformation haemorrhagic Mantle cell lymphoma stage IV – Basic Information Familial haemophagocytic lymphohistiocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cerebrolysin Concentrate Gsk4381562A Urea Sapropterin Dihydrochloride Sodium S-Lactate Solution Sym023 Bgb-15025 Citrate Peposertib Nnc0194-0499 Ibuprofen Sodium Dihydrate Mogamulizumab Glycine Syn2 Setmelanotide Terlipressin Minoxidil Bemnifosbuvir Hemisulfate Rgx-202 Lomustine VINBLASTINE More therapies…

    Learn about Your Condition

    Dysmenorrhoea Pustular psoriasis Clostridium difficile colitis Radicular pain Short-bowel syndrome Burning mouth syndrome Chronic kidney disease Retinitis pigmentosa Metabolic syndrome Morning sickness Endometrial cancer stage I Hypotransferrinaemia Hidradenitis Traumatic pain Gastrointestinal melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary tract disorder
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    France Germany Italy Spain

  • Study on the Effectiveness of Infliximab for Children with Inflammatory Bowel Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    Investigated Drugs:
    • Infliximab
    Italy

  • Study on Oral and Enema Fecal Microbiota Transplantation for Children with Ulcerative Colitis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    France

  • Study of Donor Specific Immunomodulatory Cells (DSIMC) for Patients with End-Stage Liver Disease Undergoing Liver Transplantation

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Liver transplant
    Investigated Drugs:
    • Dsimc
    Sweden

  • A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Elafibranor
    Austria Belgium Czechia Denmark Finland France +9

  • Study on Treating Chronic Anal Fissure in Patients Using Ultrasound-Guided Injections of Botulinum Toxin A

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    Spain
Previous Page
1 … 56 57 58 59 60 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!